Cellectar Biosciences Inc (NASDAQ:CLRB)
| 2.20 Delayed Data As of Nov 28 |  +0.09 / +4.21%Today’s Change | 1.25 Today|||52-Week Range 3.15 | +28.65% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Assets | Cash | 3.9M | 11.4M | 10.0M | 13.3M | |
| Short Term Investment Cash | -5.6M | 7.6M | -1.4M | 3.2M | ||
| Cash & Short Term Investments | 3.9M | 11.5M | 10.1M | 13.3M | ||
| Receivables | Receivables | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Inventories | Inventories | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Current Assets | Other Current Assets | 267.8K | 693.6K | 878.0K | 641.2K | |
| Current Assets | 4.2M | 12.2M | 10.9M | 14.0M | ||
| Total Assets | Property, Plant and Equipment - Gross | 5.7M | 5.7M | 6.1M | 724.5K | |
| Depreciation | -3.9M | -4.3M | -5.8M | -181.2K | ||
| Intangible Assets | 1.7M | 1.7M | 1.7M | 0.00 | ||
| Other Assets | 1.7M | 1.7M | 1.7M | 558.9K | ||
| Total Assets | 7.6M | 15.3M | 12.9M | 15.1M | ||
| Liabilities | Accounts Payable | 0.00 | 0.00 | 1.9M | 1.5M | |
| Short Term Debt | 246.0K | 89.3K | 3.0K | 2.2K | ||
| Accrued Expenses | 675.9K | 1.4M | 138.9K | 33.1K | ||
| Other Current Liabilities | 5.5M | 1.5M | 244.0K | 76.1K | ||
| Other Liabilities | 5.7M | 1.6M | 2.1M | 1.6M | ||
| Total Liabilities | Long Term Debt | 94.6K | 5.2K | 2.2K | 0.00 | |
| Other Liabilities | 148.9K | 146.6K | 0.00 | 171.0K | ||
| Total Liabilities | 5.9M | 1.8M | 2.1M | 1.8M | ||
| Equity | Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Preferred Stock | 0.00 | 875.6K | 995.8K | 2.5M | ||
| Common Equity | 1.6M | 12.7M | 9.8M | 10.7M | ||
| Total Shareholder Equity | 1.6M | 13.5M | 10.8M | 13.3M | ||
| Share Information | Common Shares Outstanding | 85.8K | 1.0M | 1.7M | 4.7M | |
| Addtl. Info. | No data currently available for this section. | |||||
